MOGO Moringa LLC — Class I: MOGO PURE MORINGA OLEIFERA CAPSULES, HERBAL SUPPLEMENT, 180 QUICK RELEASE VEGGIE CAPSULE,
MOGO Moringa LLC has initiated a Class I recall for its MOGO Pure Moringa Oleifera Capsules (180 count) due to potential contamination with Salmonella Typhimurium. The recall covers the 350 mg veggie capsules marketed as a herbal supplement manufactured in the USA.
Dietary supplement manufacturers, distributors, and quality assurance professionals involved in the botanical supplement supply chain, specifically those handling moringa-based products.
A Class I designation indicates the FDA's assessment of a reasonable probability that exposure to the product will cause serious adverse health consequences or death. This suggests a significant breakdown in pathogen control programs or raw material qualification processes. The 'Ongoing' status implies that the firm is currently managing the removal or correction of the affected lots under FDA oversight, which typically requires intensive documentation and effectiveness checks.
Quality teams should immediately verify if this product is in their inventory or supply chain and initiate quarantine procedures. Firms utilizing moringa leaf powder should audit their raw material suppliers for Salmonella testing protocols and COA (Certificate of Analysis) veracity. Regulatory departments should monitor the status of this ongoing Class I recall for further distribution updates.
Class I. Reason: Product may be contaminated with Salmonella Typhimurium. Product: MOGO PURE MORINGA OLEIFERA CAPSULES, HERBAL SUPPLEMENT, 180 QUICK RELEASE VEGGIE CAPSULE, 100% PURE, 350 MG PER CAPSULE, SUPPLEMENT FACTS MORINGA POWDER 1050 mg, Ingredients: 100% Pure Moringa Leaf Powder (Moringa Oleifera), MANUFACTURED IN USA AND Marketed by: MOGO MIRINGA LLC, PO BOX 32066 Saint Louis, MO 63132. Firm: MOGO Moringa LLC (Saint Louis MO United States). Status: Ongoing.
Open in openFDA / FDA.gov